Gene · 6555
Papers1,442
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 1,442
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Construction of an immune-related risk score signature for gastric cancer based on multi-omics data. | Sci Rep | 2024 | 38228846 | PubTator, text mining | PubMed |
| Opinion paper on the diagnosis and treatment of progressive familial intrahepatic cholestasis. | JHEP Rep | 2024 | 38192535 | PubTator, text mining | PubMed |
| The gut-liver axis in hepatobiliary diseases. | Inflamm Regen | 2024 | 38191517 | PubTator, text mining | PubMed |
| Bile salt signaling and bile salt-based therapies in cardiometabolic disease. | Clin Sci (Lond) | 2024 | 38180064 | PubTator, text mining | PubMed |
| The impact of SLC10A3 on prognosis and immune microenvironment in colorectal adenocarcinoma. | Eur J Med Res | 2024 | 38178258 | PubTator, text mining | PubMed |
| Exploiting Apical Sodium-Dependent Bile Acid Transporter (ASBT)-Mediated Endocytosis with Multi-Functional Deoxycholic Acid Grafted Alginate Amide Nanoparticles as an Oral Insulin Delivery System. | Pharm Res | 2024 | 38114803 | PubTator, text mining | PubMed |
| Combined inhibition of bile salt synthesis and intestinal uptake reduces cholestatic liver damage and colonic bile salts in mice. | JHEP Rep | 2024 | 38074508 | PubTator, text mining | PubMed |
| Transcriptionally activates CCL28 expression to inhibit M2 polarization of macrophages and prevent immune escape in colorectal cancer cells. | Transl Oncol | 2024 | 38035446 | PubTator, text mining | PubMed |
| Identification of hypoxia-related gene signatures based on multi-omics analysis in lung adenocarcinoma. | J Cell Mol Med | 2024 | 38013642 | PubTator, text mining | PubMed |
| Paediatric research sets new standards for therapy in paediatric and adult cholestasis. | Lancet Child Adolesc Health | 2024 | 38006895 | PubTator, text mining | PubMed |
| Loss of SLC27A5 Activates Hepatic Stellate Cells and Promotes Liver Fibrosis via Unconjugated Cholic Acid. | Adv Sci (Weinh) | 2024 | 37957540 | PubTator, text mining | PubMed |
| Inhibition of the renal apical sodium dependent bile acid transporter prevents cholemic nephropathy in mice with obstructive cholestasis. | J Hepatol | 2024 | 37939855 | PubTator, text mining | PubMed |
| Targeted LC-MS/MS profiling of bile acids reveals primary/secondary bile acid ratio as a novel biomarker for necrotizing enterocolitis. | Anal Bioanal Chem | 2024 | 37938412 | PubTator, text mining | PubMed |
| Intestinal in vitro transport assay combined with physiologically based kinetic modeling as a tool to predict bile acid levels in vivo. | ALTEX | 2024 | 37528756 | PubTator, text mining | PubMed |
| Infant and Adult Human Intestinal Enteroids are Morphologically and Functionally Distinct. | bioRxiv | 2024 | 37292968 | PubTator, text mining | PubMed |
| Endogenous retroviruses Suppressyn and Syncytin-2 as innovative prognostic biomarkers in Acute Myeloid Leukemia. | Front Cell Infect Microbiol | 2023 | 38274728 | PubTator, text mining | PubMed |
| Recent Advances in the Gastrointestinal Complex in Vitro Model for ADME Studies. | Pharmaceutics | 2023 | 38258048 | PubTator, text mining | PubMed |
| Targeting Farnesoid X Receptor in Tumor and the Tumor Microenvironment: Implication for Therapy. | Int J Mol Sci | 2023 | 38203175 | PubTator, text mining | PubMed |
| Totum-070, a Polyphenol-Rich Plant Extract, Prevents Hypercholesterolemia in High-Fat Diet-Fed Hamsters by Inhibiting Intestinal Cholesterol Absorption. | Nutrients | 2023 | 38140315 | PubTator, text mining | PubMed |
| Cranberry Proanthocyanidins Mitigate Reflux-Induced Transporter Dysregulation in an Esophageal Adenocarcinoma Model. | Pharmaceuticals (Basel) | 2023 | 38139823 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6555/papers?page=6